A Phase I Study of Nab-Paclitaxel, Gemcitabine and AZD1775 for Treatment of Metastatic Adenocarcinoma of the Pancreas: ECOG-ACRIN EA2131
- DOI
- 10.1016/j.clcc.2026.08.004
- Published
- 2026-09
- Container
- Clinical Colorectal Cancer
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.clcc.2026.08.004,
title = {A Phase I Study of Nab-Paclitaxel, Gemcitabine and AZD1775 for Treatment of Metastatic Adenocarcinoma of the Pancreas: ECOG-ACRIN EA2131},
author = {Jennifer R. Eads and Ju-Whei Lee and Cheng E. Chee and Neal J. Meropol and Al B. Benson and Paul Catalano and Efrat Dotan and Dana B. Cardin and Peter J. O’Dwyer},
year = {2026},
journal = {Clinical Colorectal Cancer},
doi = {10.1016/j.clcc.2026.08.004},
url = {https://doi.org/10.1016/j.clcc.2026.08.004}
}RIS
TY - JOUR TI - A Phase I Study of Nab-Paclitaxel, Gemcitabine and AZD1775 for Treatment of Metastatic Adenocarcinoma of the Pancreas: ECOG-ACRIN EA2131 AU - Jennifer R. Eads AU - Ju-Whei Lee AU - Cheng E. Chee AU - Neal J. Meropol AU - Al B. Benson AU - Paul Catalano AU - Efrat Dotan AU - Dana B. Cardin AU - Peter J. O’Dwyer PY - 2026 JO - Clinical Colorectal Cancer DO - 10.1016/j.clcc.2026.08.004 UR - https://doi.org/10.1016/j.clcc.2026.08.004 ER -
APA
Eads, J. R., Lee, J., Chee, C. E., Meropol, N. J., Benson, A. B., Catalano, P., Dotan, E., Cardin, D. B., & O’Dwyer, P. J. (2026). A Phase I Study of Nab-Paclitaxel, Gemcitabine and AZD1775 for Treatment of Metastatic Adenocarcinoma of the Pancreas: ECOG-ACRIN EA2131. Clinical Colorectal Cancer. https://doi.org/10.1016/j.clcc.2026.08.004
Source records
- crossref · retrieved 2026-09-25T11:06:33.379Z